While Beta Bionics Inc has overperformed by 1.39%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, BBNX fell by -13.29%, with highs and lows ranging from $26.66 to $8.89, whereas the simple moving average jumped by 23.25% in the last 200 days.
On October 01, 2025, Goldman Upgraded Beta Bionics Inc (NASDAQ: BBNX) to Buy. A report published by Truist on June 16, 2025, Initiated its previous ‘Buy’ rating for BBNX. Lake Street also rated BBNX shares as ‘Buy’, setting a target price of $30 on the company’s shares in an initiating report dated June 12, 2025. Wolfe Research Initiated an Outperform rating on May 30, 2025, and assigned a price target of $20. Goldman initiated its ‘Neutral’ rating for BBNX, as published in its report on May 30, 2025. Stifel’s report from February 24, 2025 suggests a price prediction of $25 for BBNX shares, giving the stock a ‘Buy’ rating. Piper Sandler also rated the stock as ‘Overweight’.
Analysis of Beta Bionics Inc (BBNX)
Further, the quarter-over-quarter increase in sales is 54.45%, showing a positive trend in the upcoming months.
Beta Bionics Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -81.35% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 13.79, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and BBNX has an average volume of 754.24K. On a monthly basis, the volatility of the stock is set at 7.08%, whereas on a weekly basis, it is put at 7.93%, with a loss of -7.41% over the past seven days. Furthermore, long-term investors anticipate a median target price of $25.33, showing growth from the present price of $20.49, which can serve as yet another indication of whether BBNX is worth investing in or should be passed over.
How Do You Analyze Beta Bionics Inc Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 24.65%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 91.85% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
